Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure
- 31 August 1995
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 26 (2), 438-445
- https://doi.org/10.1016/0735-1097(95)80020-h
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Losartan in Heart FailureCirculation, 1995
- Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure.Circulation, 1993
- Nonpeptide angiotensin II receptor antagonists. Studies with DuP 753 and EXP3174 in dogsEuropean Journal of Pharmacology, 1991
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- DuP 753 is a specific antagonist for the angiotensin receptor.Hypertension, 1991
- Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.Circulation, 1991
- Hemodynamic effects of renin inhibition by enalkiren in chronic congestive heart failureThe American Journal of Cardiology, 1991
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.Heart, 1985
- Effect of the renin-angiotensin system on limb circulation and metabolism during exercise in patients with heart failureJournal of the American College of Cardiology, 1985